Innate Pharma innate-pharma.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Innate Pharma is a biopharmaceutical company developing drugs targeting innate immunity. The Company is developing three product platforms (gamma delta T cells, NK cells and TLR), each directly or indirectly validated in clinical oncology settings. Innate Pharma's drug candidates also have development potential in the treatment of infectious disease and chronic inflammation.

Innate Pharma is a biopharmaceutical company developing drugs targeting innate immunity. The Company is developing three product platforms (gamma delta T cells, NK cells and TLR), each directly or indirectly validated in clinical oncology settings. I...Show all

Company (IPO / Went public)

Phone: 33 (0)4 30 30 30 30

Fax:

117, Avenue de Luminy - BP 30191

Marseille, 13009
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Innate Pharma $50M Oct 23, 2018
Inhibitex $209.8M Aug 12, 2005
Callisto Pharmaceuticals $27.2M Jan 18, 2013
See all 44 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Innate Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors
See all 44 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Tlr3 binding agents May 30, 2013 Apr 17, 2018 Patent
Pan-kir2dl nk-receptor antibodies and their use in diagnostics and therapy Jul 01, 2004 Feb 27, 2018 Patent
Methods for treatment of recurrent hematological malignancies Nov 22, 2011 Dec 19, 2017 Patent
Anti-kir3d antibodies Oct 28, 2015 Nov 28, 2017 Patent
Combination of anti-kir and anti-ctla-4 antibodies to treat cancer Oct 23, 2013 Oct 17, 2017 Patent
See all 67 patents